Present and future management of prostate cancer.
de Vere White
R
R
D000230:Adenocarcinoma / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D001706:Biopsy; D019090:Case Management; D002423:Cause of Death; D017679:Cryotherapy; D018572:Disease-Free Survival; D005544:Forecasting; D019254:Genes, bcl-2; D016158:Genes, p53; D006801:Humans; D008297:Male; D008403:Mass Screening; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D010173:Palpation; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D015996:Survival Rate; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D014810:Vitamin E; D017430:Prostate-Specific Antigen